Specifically, ALKBH5 is a critical regulator in the development of several cancers, including thyroid cancer, hypopharyngeal carcinoma, non-small cell lung cancer (NSCLC), and glioblastoma (GBM). This evidence concerns the gene ALKBH5 and thyroid cancer.